The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism

European Journal of Cancer

Volumn 43, Issue 10, 2007, Pages 1590-1595

  Juárez Cedillo, Teresa ^a   Vallejo, Maite ^b   Fragoso, José Manuel ^b   Hernández Hernández, Dulce Maria ^c   Rodríguez Pérez, José Manuel ^b   Sánchez García, Sergio ^a   del Carmen García Peña, María ^a   García Carrancá, Alejandro ^d   Mohar Betancourt, Alejandro ^e   Granados, Julio ^f   Vargas Alarcón, Gilberto ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^f INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Carcinogenic; Cervical cancer; Genetic susceptibility; Genotypes; Human papilloma virus; P450 cytochrome; Polymerase chain reaction; Polymorphisms; Risk factors; Smoking

Indexed keywords

CYTOSINE; THYMINE;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CHILDBIRTH; CONTROLLED STUDY; CYP1A1 GENE; DELIVERY; EVALUATION; EXON; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MEXICO; MSPI GENE; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEXUALITY; SMOKING HABIT; UTERINE CERVIX CANCER;

ADULT; CYTOCHROME P-450 CYP1A1; EXONS; FEMALE; HUMANS; MEXICO; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 34250004304     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.03.025     Document Type: Article

References (30)

1. Garci{dotless}́a-Carrancá A. Vaccine against human papillomavirus and perspectives for the prevention and control of cervical cancer. Salud Publica Mex 45 (2003) S443-S448
2. Zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In: Zur Hausen H. (Ed). Human pathogenic papillomaviruses (1994), Springer-Verlag, Heidelberg (Germany) 131-156
3. Cuzick J., Terry G., Ho L., Hollingworth T., and Anderson M. Type-specific human papillomavirus DNA in abnormal smears as predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 6 (1994) 167-171
4. Parazzini F., La Vecchia C., Negri E., Cecchetti G., and Fedele L. Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia. Br J Cancer 59 (1989) 805-809
5. Caporaso N., and Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 5 (1995) 59-63
6. Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 71 (1997) 1-3
7. Bartsch H., and Hietanen E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect 104 Suppl. 3 (1996) 569-577
8. Doll R. Uncovering the effects of smoking: historical perspective. Stat Meth Med Res 7 (1998) 87-117
9. Bergen A.W., and Caporaso N. Cigarette smoking. J Natl Cancer Inst 91 (1999) 1365-1375
10. Coles B., and Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25 (1990) 47-70
11. Kriek E., Rojas M., Alexandrov K., and Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat Res 400 (1998) 215-231
12. Hecht S.S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424 (1999) 127-142
13. Chung F.L., Chen H.J.C., and Nath R.G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 17 (1996) 2105-2111
14. Nath R.G., Ocando J.E., Guttenplan J.B., and Chung F.L. 1,N2-Propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Cancer Res 58 (1998) 581-584
15. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., and Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263 (1999) 131-133
16. Goodman M.T., McDuffie K., Hernandez B., et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81 (2001) 263-269
17. Hayashi S.I., Watanabe J., Nakachi K., and Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 19 (1991) 4797
18. Wang X.L., Greco M., Sim A.S., Duarte N., Wang J., and Wilcken D.E. Effect of CYP1A1 Msp I polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis 162 (2002) 391-397
19. Hayashi S.I., Watanabe J., Nakachi K., and Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 110 (1991) 407-411
20. Bronfman M., Guiscafré H., Castro V., Castro R., and Gutiérrez G. Medición de la desigualdad: una estrategia metodológica, análisis de las caracteri{dotless}́sticas socioeconómicas de la muestra. Arch Invest Med 19 (1988) 351-360
21. Persson I., Johansson I., and Ingelman-Sundberg M. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun 231 (1997) 227-230
22. Shen J., Wang R.T., Xu Y.C., Wang L.W., and Wang X.R. Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol 11 (2005) 6056-6060
23. Song N., Tan W., Xing D., and Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in china. Carcinogenesis 22 (2001) 11-16
24. Crofts F., Taioli E., Trachman J., et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15 (1994) 2961-2963
25. Kihara M., Kihara M., and Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16 (1995) 2331-2336
26. Petersen D.D., Kong A.N.T., Jorge L.F., Nebert D.W., and Arias T.D. Debrisoquine polymorphism: Novel CYP2D6 gene Bam HI RFLP in the Ngawbe Guaymi Indian of Panama. Pharmacogenetics 1 (1991) 136-142
27. Crofts F., Cosma G.N., Currie D., Taioli E., Toniolo P., and Garte S.J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 14 (1993) 1729-1731
28. Fragoso J.M., Juarez-Cedillo T., Hernandez-Pacheco G., et al. Cytochrome P4501A1 polymorphisms in the Amerindian and Mestizo populations of Mexico. Cell Biochem Funct 23 (2005) 189-193
29. Frega A., Stentella P., De Ioris A., et al. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence. Cancer Lett 10 (2003) 127-134
30. Phillips A.N., and Smith G.D. Cigarette smoking as a potential cause of cervical cancer: has confounding been controlled?. Int J Epidemiol 23 (1994) 42-49